Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Physicians who Treat Hypertension (US)

Council Members in this Study Group: 797

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Harold Bays, MD, President and Medical Director, L-MARC Research CenterHarold Bays, MD

President and Medical Director
L-MARC Research Center
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Harold Bays, MD, FACP, FACE, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...

Charles O'Shaughnessy, MD

Director of Interventional Cardiology
NORTH OHIO HEART CENTER, INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Charles O'Shaughnessy, MD, is the Director of Interventional Cardiology at North Ohio Heart Center, Ohio. Dr. O'Shaughnessy's clinical interests are in interventional cardiology including balloon angioplasty, laser directional atherectomy, stent placement, and rotoblator. He is very active in clinical...

Rohit Arora, MD

Professor of Medicine
Finch University of Health Science-Chicago Medical School
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Rohit Arora, MD, FACC, FAHA, FASCI, FACP, is Professor of Medicine and Professor of Physiology and Biophysics at Chicago Medical School. He is also the Chairman of Cardiology and Associate Chairman of Medicine in the Department of Medicine. Previously, he was Chief of Cardiology at UMDNJ and Director...

Paul Gurbel, MD

Director of Cardiovascular Research
Sinai Hospital of Baltimore, Inc.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Paul Gurbel, MD, is Director of Cardiovascular Research at the Center for Thrombosis Research at Sinai Hospital of Baltimore. Dr. Gurbel has authored over 100 peer-reviewed papers related primarily to coronary thrombosis and interventional cardiology. His particular expertise is in translational platelet...

Daniel Fisher, MD, FACC, FACP

Cardiologist
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Daniel Fisher, MD, FACC, FACP, is a Cardiologist at NYU Medical Center. He has a private practice in Cardiology and specializes in non-invasive cardiology. Dr. Fisher is board certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. He has lectured frequently on such topicsas...

1 recent news post(s)
Hossein Ardehali, MD, PhD, Assistant Professor, Northwestern University, Feinberg School of MedicineHossein Ardehali, MD, PhD

Assistant Professor
Northwestern University, Feinberg School of Medicine
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Hossein Ardehali, MD, PhD, is an Assistant Professor of Medicine at Feinberg Cardiovascular Institute in Illinois. His specialties include lipid metabolism, preventive cardiology, electrophysiology and heart failure. Dr. Ardehali's basic science research interest is in the areas of reperfusion injury...

2 recent news post(s)
Howard Weintraub, MD

Clinical Director
NEW YORK UNIVERSITY (INC)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Howard Weintraub, MD, FACC, is the Clinical Director of Center for the Prevention of Cardiovascular Disease at NYU Medical Center. He has been a consultant for several organizations and has been a Cardiologist for the National Football League. Dr. Weintraub has written textbook chapters on evaluation...

4 recent news post(s)
Marina Raikhel, MD, Director, TORRANCE MEMORIAL MEDICAL CENTERMarina Raikhel, MD

Director
TORRANCE MEMORIAL MEDICAL CENTER
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Marina Raikhel, MD, is an active family practitioner with a particular interest in primary care and ob/gyn focus. She has expertise in the treatment of a wide variety of internal medicine conditions, with special focus on diabetes, hypertension, obesity, anxiety, and depression. She is Director ofTorrance...

1 recent news post(s)

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Ghana Targets Health Tourism Boom: More Evidence of Globalization

October 31, 2009

GLG Expert Contributor

Ghana targets health tourism boom | news.bbc.co.uk

Just as high tech products are manufactured in Asian countries for a fraction of the cost, medical procedures will be provided in less developed countries for a fraction of the cost in the not so distant future.It will initially be low tech procedures such as cosmetic operations and minor procedures...

Percutaneous valve repair – next battle among cardiovascular device companies?

October 4, 2009

GLG Expert Contributor

Abbott To Acquire Evalve, Inc., A Leader In Minimally Invasive Cardiac Valve Repair Technology | www.medicalnewstoday.com

By acquiring promising technology in the percutaneous valve arena, as well as enjoying an already established reputation among interventional cardiologists, Abbott will position itself as a major player in an emerging technology market, and become a comprehensive provider for interventional cardiology...

A new treatment for a major problem.

September 30, 2009

GLG Expert Contributor

ACC: Device May Prevent Stroke in AF Patients | www.medpagetoday.com

Atrial fibrillation is a very common condition that significantly increase the risk of stroke, especially in the older population. Vitamin K antagonists are the only current effective treatment in the higher risk population to reduce stroke. Any new treatment has a huge potential to help reduce risk,...

Metanalyses, Metapsychoses

September 30, 2009

Ronald Innerfield, MD, Vice President of Clinical Affairs, Evidence Based Medicine, Inc.

Controls to blood sugar 'cuts stroke risk' | www.barchester.com

There have been many epidemiologic studies showing a very tight correlation between baseline A1c and cardiovascular mortalityDespite this, five major randomized prospective studies have failed to show any macrovascular benefit for tighter glucose controlThe logical conclusion is that glucose is, therefore,...

How much market will MADIT-CRT drive?

September 30, 2009

GLG Expert Contributor

Cardiac-Resynchronization Therapy for the Prevention of Heart Failure Events | content.nejm.org

While this trial had a positive endpoint, it was not a mortality endpoint.   A major defect is a lack of a medical therapy alone arm.  That said, prevention of heart failure episodes is a laudable goal and given the expense to the US system of CHF, this could be a worthwhile treatment, however thenumber...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Partner
  • Physician - Division Head
  • President

Related Study Groups

Study Group Name No. Members
Heart Failure Specialists (US) 978
General Cardiologists (US) 1333
Non-Electrophysiologist Cardiologists (US) 860
Physicians who Treat Arrhythmia (US) 306
Physicians who Treat Hypercholesterolemia in the U.S. 251
Interventional Cardiologists (US) 438
Niaspan Prescribers for Raising HDL 144

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Physicians who Treat Hypertension (US) Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Physicians who Treat Hypertension (US) have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare